Ryan Pearson, PhD, of the University of Maryland School of Pharmacy is moving forward with a unique approach to defeating sepsis using nanoparticles.

Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, of the School of Pharmacy is working to ensure drug delivery through the skin is safe and effective and just the right dose.

Paul Shapiro, PhD, and Jeffrey Hasday, MD, are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases.

Allan Doctor, MD, of the School of Medicine and Joga Gobburu, PhD, MBA, of the School of Pharmacy are optimistic they are on the cusp of developing the world’s first viable artificial blood.